Mirum Pharmaceuticals appoints Rob Myers as Chief Medical Officer
Mirum Pharmaceuticals (MIRM) appointed Rob Myers, M.D., as Chief Medical Officer, effective September 21, 2026. He will join the leadership team and lead the company’s global medical and clinical development function.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.